India likely to approve two-dose regimen for COVID vaccines, 4 weeks apart
India's drugs regulator is likely to approve administering two doses of the AstraZeneca/Oxford vaccine and another locally-developed one by Bharat Biotech, each four weeks apart, two sources with knowledge of the matter told Reuters on Saturday.
from bdnews24.com - Home https://ift.tt/3ncDuT4
from bdnews24.com - Home https://ift.tt/3ncDuT4
No comments